2011
DOI: 10.1111/j.1365-2796.2011.02427.x
|View full text |Cite
|
Sign up to set email alerts
|

The Human Protein Atlas as a proteomic resource for biomarker discovery

Abstract: Abstract. Pontén F, Schwenk JM, Asplund A, Edqvist P-HD

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

2
202
0
3

Year Published

2011
2011
2021
2021

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 240 publications
(207 citation statements)
references
References 95 publications
(117 reference statements)
2
202
0
3
Order By: Relevance
“…specific antibodies on a global scale combining high-throughput generation of affinity-purified polyclonal antibodies with immunohistochemistry-based protein profiling on tissue and cell microarrays (Ponten et al, 2011). All protein expression data, are published on the free and publically available Human Protein Atlas portal (www.proteinatlas.org; Uhlen et al, 2005Uhlen et al, , 2010.…”
Section: Discussionmentioning
confidence: 99%
“…specific antibodies on a global scale combining high-throughput generation of affinity-purified polyclonal antibodies with immunohistochemistry-based protein profiling on tissue and cell microarrays (Ponten et al, 2011). All protein expression data, are published on the free and publically available Human Protein Atlas portal (www.proteinatlas.org; Uhlen et al, 2005Uhlen et al, , 2010.…”
Section: Discussionmentioning
confidence: 99%
“…The need for a wider range of less expensive affinity reagents is the subject of several large development programs. The Human Protein Atlas Project has developed a genecentered pipeline for the systematic generation and validation of affinity-purified polyclonal antibodies [41,101]. The starting point for this pipeline is the identification in silico of 80-100 amino acid epitope tags that have low homology with other proteins.…”
Section: The Systematic Generation Of More Affinity Moleculesmentioning
confidence: 99%
“…Immunohistochemistry plays vital role in histological diagnosis, and the immunohistochemical markers could be used for estimating prognosis and predicting therapy response (Ordóñez, 2013). The HPA is built based on immunohistochemistry data, and provides a reliable proteomic resource for biomarker discovery (Pontén et al, 2011). It is a powerful platform not only to provide immunohistochemical mapping but also to provide quantitative protein expression profiles across different tissues.…”
Section: Introductionmentioning
confidence: 99%